Skip to main content
Erschienen in: World Journal of Surgery 6/2012

01.06.2012

Evaluation of Postoperative Radioactive Iodine Scans in Patients who Underwent Prophylactic Central Lymph Node Dissection

verfasst von: Amanda M. Laird, Paul G. Gauger, Barbra S. Miller, Gerard M. Doherty

Erschienen in: World Journal of Surgery | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Prophylactic central lymph node dissection (CLND) accompanying total thyroidectomy for papillary thyroid cancer (PTC) remains controversial. Our hypothesis is that CLND may help select patients who benefit from postoperative radioactive iodine (RAI).

Methods

A total of 119 patients who were clinically node-negative underwent total thyroidectomy/bilateral CLND for papillary thyroid cancer (PTC) > 1 cm during 2002–2010. Pathology results, RAI results, and outcomes were compared between node-positive (NP) and node-negative (NN) patients.

Results

NP and NN patients were similar in age, gender, tumor size, and MACIS score. Median number of nodes excised was six. The rate of permanent hypocalcemia was 1.7% without permanent recurrent laryngeal nerve injuries. Thirteen of 52 (25%) NN patients and 24 of 67 (36%) NP patients had suspicious nodes by intraoperative inspection. The node assessment negative predictive value was 75%; positive predictive value was 36%. Fifty-six percent (67/118) were NP; 100 patients were treated with RAI. Fourteen of 62 NP patients had abnormal postoperative RAI scans aside from the thyroid remnant versus 4 of 38 NN patients (23 vs. 11%, p = 0.18). Median 1-year stimulated thyroglobulin (Tg) level was 0.0 for both (range 0.0–1.2, NN; 0.0–22.7, NP; p = 0.1). NP patients received higher doses of RAI (150 vs. 30 mCi, p < 0.001). Rate of recurrent or persistent disease was 3.4%.

Conclusions

Few node-negative patients have abnormal RAI scans outside of the thyroid bed. Node-positive patients had greater variability in stimulated 1-year Tg levels after higher doses of RAI. CLND may identify the patients most likely to have persistently elevated stimulated Tg after initial therapy for PTC.
Literatur
1.
Zurück zum Zitat Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [Practice Guideline]. Thyroid 19(11):1167–1214PubMedCrossRef Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [Practice Guideline]. Thyroid 19(11):1167–1214PubMedCrossRef
2.
Zurück zum Zitat Roh JL, Park JY, Park CI (2007) Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 245(4):604–610PubMedCrossRef Roh JL, Park JY, Park CI (2007) Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 245(4):604–610PubMedCrossRef
3.
Zurück zum Zitat Mazzaglia PJ (2010) Surgeon-performed ultrasound in patients referred for thyroid disease improves patient care by minimizing performance of unnecessary procedures and optimizing surgical treatment. World J Surg 34(6):1164–1170. doi:10.1007/s00268-010-0402-y PubMedCrossRef Mazzaglia PJ (2010) Surgeon-performed ultrasound in patients referred for thyroid disease improves patient care by minimizing performance of unnecessary procedures and optimizing surgical treatment. World J Surg 34(6):1164–1170. doi:10.​1007/​s00268-010-0402-y PubMedCrossRef
4.
Zurück zum Zitat Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB (2003) Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer [Comparative Study]. Surgery 134(6):946–954; discussion 954–955PubMedCrossRef Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB (2003) Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer [Comparative Study]. Surgery 134(6):946–954; discussion 954–955PubMedCrossRef
5.
Zurück zum Zitat Tisell LE, Nilsson B, Molne J, Hansson G, Fjalling M, Jansson S, Wingren U (1996) Improved survival of patients with papillary thyroid cancer after surgical microdissection [research support, non-U.S. Gov’t]. World J Surg 20(7):854–859. doi:10.1007/s002689900130 PubMedCrossRef Tisell LE, Nilsson B, Molne J, Hansson G, Fjalling M, Jansson S, Wingren U (1996) Improved survival of patients with papillary thyroid cancer after surgical microdissection [research support, non-U.S. Gov’t]. World J Surg 20(7):854–859. doi:10.​1007/​s002689900130 PubMedCrossRef
6.
Zurück zum Zitat Bardet S, Malville E, Rame JP, Babin E, Samama G, De Raucourt D, Michels JJ, Reznik Y, Henry-Amar M (2008) Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma (research support, non-U.S. Gov’t). Eur J Endocrinol 158(4):551–560PubMedCrossRef Bardet S, Malville E, Rame JP, Babin E, Samama G, De Raucourt D, Michels JJ, Reznik Y, Henry-Amar M (2008) Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma (research support, non-U.S. Gov’t). Eur J Endocrinol 158(4):551–560PubMedCrossRef
7.
Zurück zum Zitat Hackshaw A, Harmer C, Mallick U, Haq M, Franklyn JA (2007) 131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review. J Clin Endocrinol Metab 92(1):28–38PubMedCrossRef Hackshaw A, Harmer C, Mallick U, Haq M, Franklyn JA (2007) 131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review. J Clin Endocrinol Metab 92(1):28–38PubMedCrossRef
8.
Zurück zum Zitat Moo TA, McGill J, Allendorf J, Lee J, Fahey T 3rd, Zarnegar R (2010) Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg 34(6):1187–1191. doi:10.1007/s00268-010-04180-3 PubMedCrossRef Moo TA, McGill J, Allendorf J, Lee J, Fahey T 3rd, Zarnegar R (2010) Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg 34(6):1187–1191. doi:10.​1007/​s00268-010-04180-3 PubMedCrossRef
9.
Zurück zum Zitat Hughes DT, White ML, Miller BS, Gauger PG, Burney RE, Doherty GM (2010) Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 148(6):1100–1106; discussion 1106–1107PubMedCrossRef Hughes DT, White ML, Miller BS, Gauger PG, Burney RE, Doherty GM (2010) Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 148(6):1100–1106; discussion 1106–1107PubMedCrossRef
10.
Zurück zum Zitat Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Al Ghuzlan A, Chami L, Schlumberger M, Travagli JP (2009) Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94(4):1162–1167PubMedCrossRef Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Al Ghuzlan A, Chami L, Schlumberger M, Travagli JP (2009) Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94(4):1162–1167PubMedCrossRef
11.
Zurück zum Zitat Carty SE, Cooper DS, Doherty GM, Duh QY, Kloos RT, Mandel SJ, Randolph GW, Stack BC Jr, Steward DL, Terris DJ, Thompson GB, Tufano RP, Tuttle RM, Udelsman R (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer [Consensus Development Conference]. Thyroid 19(11):1153–1158PubMedCrossRef Carty SE, Cooper DS, Doherty GM, Duh QY, Kloos RT, Mandel SJ, Randolph GW, Stack BC Jr, Steward DL, Terris DJ, Thompson GB, Tufano RP, Tuttle RM, Udelsman R (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer [Consensus Development Conference]. Thyroid 19(11):1153–1158PubMedCrossRef
12.
Zurück zum Zitat Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18(4):559–567; discussion 567–568. doi:10.1007/BF00323765 PubMedCrossRef Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18(4):559–567; discussion 567–568. doi:10.​1007/​BF00323765 PubMedCrossRef
14.
Zurück zum Zitat Shen WT, Ogawa L, Ruan D, Suh I, Duh QY, Clark OH (2010) Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit [comparative study]. Surgery 148(2):398–403PubMedCrossRef Shen WT, Ogawa L, Ruan D, Suh I, Duh QY, Clark OH (2010) Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit [comparative study]. Surgery 148(2):398–403PubMedCrossRef
15.
Zurück zum Zitat Lundgren CI, Hall P, Dickman PW, Zedenius J (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study [research support, non-U.S. Gov’t]. Cancer 106(3):524–531PubMedCrossRef Lundgren CI, Hall P, Dickman PW, Zedenius J (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study [research support, non-U.S. Gov’t]. Cancer 106(3):524–531PubMedCrossRef
16.
Zurück zum Zitat Noguchi S, Murakami N, Yamashita H, Toda M, Kawamoto H (1998) Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 133(3):276–280PubMedCrossRef Noguchi S, Murakami N, Yamashita H, Toda M, Kawamoto H (1998) Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 133(3):276–280PubMedCrossRef
17.
Zurück zum Zitat Zetoune T, Keutgen X, Buitrago D, Aldailami H, Shao H, Mazumdar M, Fahey TJ 3rd, Zarnegar R (2010) Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol 17(12):3287–3293PubMedCrossRef Zetoune T, Keutgen X, Buitrago D, Aldailami H, Shao H, Mazumdar M, Fahey TJ 3rd, Zarnegar R (2010) Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol 17(12):3287–3293PubMedCrossRef
18.
Zurück zum Zitat Zuniga S, Sanabria A (2009) Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 135(11):1087–1091PubMedCrossRef Zuniga S, Sanabria A (2009) Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 135(11):1087–1091PubMedCrossRef
19.
Zurück zum Zitat Sawka AM, Brierley JD, Tsang RW, Thabane L, Rotstein L, Gafni A, Straus S, Goldstein DP (2008) An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer (Evaluation Studies Research Support, Non-U.S. Gov’t Review). Endocrinol Metab Clin North Am 37(2):457-480, x Sawka AM, Brierley JD, Tsang RW, Thabane L, Rotstein L, Gafni A, Straus S, Goldstein DP (2008) An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer (Evaluation Studies Research Support, Non-U.S. Gov’t Review). Endocrinol Metab Clin North Am 37(2):457-480, x
20.
Zurück zum Zitat Hay ID (2006) Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma [review]. J Surg Oncol 94(8):692–700PubMedCrossRef Hay ID (2006) Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma [review]. J Surg Oncol 94(8):692–700PubMedCrossRef
21.
Zurück zum Zitat Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP, Schlumberger M (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90(10):5723–5729PubMedCrossRef Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP, Schlumberger M (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90(10):5723–5729PubMedCrossRef
22.
Zurück zum Zitat Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140(6):1000–1005; discussion 1005–1007PubMedCrossRef Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140(6):1000–1005; discussion 1005–1007PubMedCrossRef
23.
Zurück zum Zitat Moley JF, Lairmore TC, Doherty GM, Brunt LM, DeBenedetti MK (1999) Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations. Surgery 126(4):673–679PubMedCrossRef Moley JF, Lairmore TC, Doherty GM, Brunt LM, DeBenedetti MK (1999) Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations. Surgery 126(4):673–679PubMedCrossRef
26.
Zurück zum Zitat Steinmuller T, Klupp J, Rayes N, Ulrich F, Jonas S, Graf KJ, Neuhaus P (2000) Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg 166(1):29–33PubMedCrossRef Steinmuller T, Klupp J, Rayes N, Ulrich F, Jonas S, Graf KJ, Neuhaus P (2000) Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg 166(1):29–33PubMedCrossRef
27.
Zurück zum Zitat Chisholm EJ, Kulinskaya E, Tolley NS (2009) Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone [meta-analysis review]. Laryngoscope 119(6):1135–1139PubMedCrossRef Chisholm EJ, Kulinskaya E, Tolley NS (2009) Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone [meta-analysis review]. Laryngoscope 119(6):1135–1139PubMedCrossRef
Metadaten
Titel
Evaluation of Postoperative Radioactive Iodine Scans in Patients who Underwent Prophylactic Central Lymph Node Dissection
verfasst von
Amanda M. Laird
Paul G. Gauger
Barbra S. Miller
Gerard M. Doherty
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 6/2012
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-012-1431-5

Weitere Artikel der Ausgabe 6/2012

World Journal of Surgery 6/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.